Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Spanish public-sector workers complain most about their work environment

July 1, 2010 9:35 am | by EurekAlert | News | Comments

(FECYT - Spanish Foundation for Science and Technology) Spanish employees from public institutions and companies report higher levels of psychological violence in their place of work than their Finnish counterparts. These are the results of a study headed by the University of...

TOPICS:

Damon Runyon Cancer Research Foundation awards $3.1M to 8 top young clinical investigators

July 1, 2010 9:33 am | by EurekAlert | News | Comments

(Damon Runyon Cancer Research Foundation) The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its April 2010 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career...

TOPICS:

Sysmex America Announces Executive Leadership Changes

July 1, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

MUNDELEIN, Ill. , July 1 /- Sysmex America Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announces executive changes in the areas of corporate affairs, operations and technical services.  John Kershaw, President & CEO, Sysmex...

TOPICS:
Advertisement

LHC Group signs deal in Alabama

July 1, 2010 8:45 am | by The Associated Press | News | Comments

Home health provider LHC Group Inc. has started a joint venture to provide service in the Montgomery, Ala., area.Lafayette-based LHC Group says the deal is with an affiliate of the University of Alabama-Birmingham Health System and Baptist Medical Center South in Montgomery.Financial terms were...

Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets

July 1, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J. , July 1 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX ) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia 's CRINONE®...

TOPICS:

Watson Launches Generic Exelon®

July 1, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J. , July 1 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has...

TOPICS:

Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elekta's Leksell Gamma Knife Perfexion

July 1, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA , July 1 /- The refinements in Elekta's Gamma Knife ® surgery technology that created the fifth generation Leksell Gamma Knife® Perfexion™ are radically changing the approach to treating brain metastases and other brain disorders. With Perfexion, physicians are...

TOPICS:

NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board

July 1, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 1 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China , today announced that it has appointed Roberto Bolli , M.D., to its Scientific Advisory Board....

TOPICS:
Advertisement

Sector Snap: Home Health Care stocks tumble

July 1, 2010 7:45 am | by The Associated Press | News | Comments

Shares of home health providers fell Thursday as the Securities and Exchange Commission formally opened an investigation into potential medicare billing fraud at Amedisys Inc. and Almost Family Inc.Amedisys said it received a subpoena for documents relating to a Senate Finance Committee...

Amedisys under Medicare billing investigation

July 1, 2010 6:45 am | by The Associated Press | News | Comments

Home health provider Amedisys Inc. said Thursday it is being investigated by the Securities and Exchange Commission over Medicare billing.The company said it received a subpoena for documents relating to a Senate Finance Committee investigation. Amedisys said it plans to cooperate with the...

FUISZ Announces Advances in Devices and Solid Dosage Form

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

MIAMI , July 1 /- FUISZ today announced two medical technology advances. First, FUISZ announced that it has received a notice of issuance from the United States Patent and Trademark Office for patent claims that cover a direct connection between prescribing physicians and blood analysis...

TOPICS:

Par Pharmaceutical Begins Shipment of Generic Zegerid®

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

WOODCLIFF LAKE, N.J. , July 1 /- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that it began shipping the 20mg/1100mg and 40mg/1100mg strengths of omeprazole and sodium bicarbonate capsules to the trade. Omeprazole and sodium bicarbonate capsules are the generic version...

TOPICS:

FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

SCHAUMBURG, Ill. , July 1 /- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's nine presentations of heparin sodium injection, USP. Heparin is a vital anticoagulant,...

TOPICS:

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology

July 1, 2010 5:33 am | by IBM | News | Comments

YORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology that will directly read and sequence human DNA quickly and efficiently. Focused on...

TOPICS:

Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTAâ„¢ for Men With Low Testosterone

July 1, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa. , July 1 /- Endo Pharmaceuticals (Nasdaq: ENDP ) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading